Compare Oscar Health Inc (OSCR) vs ProShares Ultra QQQ ETF (QLD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oscar Health Inc vs ProShares Ultra QQQ ETF — how do they compare? Oscar Health Inc trades at $33.37 (market cap $10.22B), while ProShares Ultra QQQ ETF trades at $98.43 (market cap $15.38B). The key difference: ProShares Ultra QQQ ETF is the larger of the two by market cap, and ProShares Ultra QQQ ETF is more actively traded (4,844,085 versus 4,123,394). Which is the better fit depends on your goals — on Pluang, investors hold Oscar Health Inc for 15 Days and ProShares Ultra QQQ ETF for 36 Days on average.
| OSCR | QLD | |
|---|---|---|
Market Cap | $10.22B | $15.38B |
Volume | 4,123,394 | 4,844,085 |
Sector | Health | Leveraged / Inverse |
52-Week High | $33.81 | $100.77 |
52-Week Low | $10.85 | $57.16 |
Typical Hold Time | 15 Days | 36 Days |
Enterprise Value | $6.57B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
OSCR trades at $33.1, up 0.58% on the day, with a bullish technical signal from moving averages. The company reported strong Q1 and Q2 2026 earnings beats, with revenue growth from $11.7B in 2025 to a projected $15.3B in 2026, turning to a net profit. Analyst consensus is a $34 price target, with 31% buy ratings. Recent news highlights market share gains and raised 2026 guidance following its Investor Day.
The outlook is positive, driven by execution in the ACA market and new growth avenues, but risks include rising medical costs threatening profitability and a high P/E ratio. The stock offers growth potential if margin expansion continues as guided.
QLD (ProShares Ultra QQQ ETF) trades at $97.56, down 2.66% on the day, with technical indicators showing a bullish trend supported by moving averages while oscillators remain neutral. The ETF provides 2x leveraged exposure to the Nasdaq-100 index, positioned as a less volatile alternative to triple-leveraged products. Recent institutional buying and media coverage highlight investor interest in leveraged tech exposure amid market uncertainty.
The outlook for QLD hinges on Nasdaq-100 performance, with technical support at $96 and resistance at $100. While leveraged ETFs offer amplified returns, they carry elevated risk during market downturns. Current sentiment is cautiously optimistic, but investors should be aware of decay effects and interest rate sensitivity.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →About ProShares Ultra QQQ ETF
QLD is a leveraged ETF that seeks daily investment results corresponding to 200% of the daily performance of the NASDAQ-100 Index. It achieves 2x leverage by investing in financial instruments such as swaps and is designed as a tactical trading tool for investors with a bullish (long) view on the NASDAQ-100. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.
Read more on QLD →
